Traditional Chinese Medicine Full-Link D Diagram

Strengths

• Covers the full link from planting to diagnosis with comprehensive data dimensions
• Policy support for data assetization, where compliance barriers create natural moats
• Co-creation of benchmarks with leading pharmaceutical enterprises, providing strong industry endorsement

Weaknesses

• Heavy deployment of IoT hardware with large upfront capital investment
• Trust and profit-distribution challenges in interconnecting cross-enterprise data

Opportunities

• Accelerating integration of TCM data assets into financial statements, increasing corporate willingness to pay
• TCM going global driving demand for internationalized traceability standards

Threats

• Inconsistent regional data standards, making cross-province interoperability highly difficult
• Self-built platforms by large pharmaceutical enterprises potentially squeezing the space for third-party service providers